Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

23,712articles mentioning diseases

125,551disease mentions

18,081distinct diseases extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted diseases

Showing 10,981–11,040 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.

Phelan McDermid syndrome1 Phelan-McDermid syndrome1 Philadelphia-negative chronic myeloproliferative neoplasms1 Phosphaturic mesenchymal tumours1 Phosphaturic mesenchymal tumours (PMTs)1 Physical inactivity1 PiZZ AATD1 Placenta accreta spectrum (PAS)1 Placental site trophoblastic tumour (PSTT)1 Plasmodium vivax1 Plasmodium vivax malaria1 Platypnoea Orthodeoxia syndrome1 Pleomorphic adenoma of the lacrimal gland1 Plummer–Vinson syndrome1 Pneumatosis cystoides intestinalis1 Pneumocephalus1 Pneumocystis jirovecii1 Pneumocystis jirovecii pneumonia (PJP)1 Pneumonia31 Pocket haematoma1 Polymyositis-Scleroderma1 Polyp cancers1 Polyradiculoneuropathy1 Popeye deformity1 Popliteal Plexus Block (PPB)1 Portal cavernoma (PC)1 Portal hypertension (PHTN)1 Portal vein thrombosis (PVT)1 Porto-sinusoidal vascular disease (PSVD)1 Post- Covid1 Post-COVID-19 syndrome1 Post-Stroke Cognitive Impairment1 Post-induction hypotension (PIH)1 Post-ligation cardiac syndrome (PLCS)1 Post-mastectomy Pain Syndrome (PMPS)1 Post-operative pain1 Post-procedural myocardial infarction1 Post-stroke cognitive impairment (PSCI)1 Post-subarachnoid haemorrhage-induced (SAH) vasospasm1 Post-surgical pain syndrome-thoracolumbar1 Post-traumatic chronic pain (PTCP)1 Post-tuberculosis lung disease (PTLD)1 Posterior capsule opacification (PCO)1 Posterior circulation (PC) aneurysms1 Posterior communicating artery (PCoM) aneurysms1 Posterior condylar canal dural arteriovenous fistula1 Posterior cutaneous nerve entrapment syndrome1 Postextubation swallowing disorders1 Postictal agitation1 Postmenopausal bleeding1 Postoperative atrial fibrillation (POAF)1 Postoperative microbial keratitis (MK)1 Postoperative pancreatic fistula1 Postoperative sore throat (POST)1 Postoperative urinary retention (POUR)1 Postpartum haemorrhage101 Postpartum reversible cerebral vasoconstriction syndrome (RCVS)1 Postpneumonectomy syndrome1 Postprandial distress syndrome1 Poststroke cognitive impairment (PSCI)1

View all 18,081 diseases on one page

Articles mentioning diseases

23,712 articles · page 273 of 1976

415 Treatment patterns of systemic therapies in extensive-stage small-cell lung cancer (ES-SCLC): a real-world observational study

jitc · abstract · 2025-11-04 · 9 matching annotations

96.7%

ES-SCLC small cell lung cancer tarlatamab atezolizumab durvalumab Merck Sharp & Dohme LLC carboplatin

…ons This study showed that while more than 70% of patients with ES-SCLC received ICI-containing regimens as first-line treatment, progn…

431 Immune checkpoint inhibitor for advanced cutaneous malignancies in organ transplant recipients: a case series from a single center experience

jitc · abstract · 2025-11-04 · 9 matching annotations

97.8%

Merkel cell carcinoma cutaneous malignancy melanoma squamous cell carcinoma cutaneous malignancies sirolimus Inova Schar Cancer Institute everolimus prednisone mycophenolate+4 more

…gnancies including melanoma, squamous cell carcinoma (SCC), and Merkel cell carcinoma (MCC). However, the concurrent use of ICIs and immunosuppressan…

435 ES038, a novel NKCE molecule targeting LILRB4 in AML via dual engagement of NKG2A and NKG2C

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

AML Acute myeloid leukemia ES038 LILRB4

…es NK cell activation and improves their therapeutic potential. AML, particularly in relapsed or refractory cases, remains a signif…

463 Dissecting myeloid-driven mechanisms of immunotherapy resistance in prostate cancer bone metastases

jitc · abstract · 2025-11-04 · 9 matching annotations

94.4%

metastatic castration-resistant prostate cancer mCRPC pancreatic ductal carcinoma prostate cancer ipilimumab enzalutamide J Clin Oncol Atezolizumab

…al. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nat Med. 2022;28:144–53.Koo KC, Pa…

546 Sarilumab as a potential mitigator of ubamatamab (MUC16×CD3)-induced cytokine release syndrome (CRS) in patients with advanced ovarian cancer (OC) or endometrial cancer (EC)

jitc · abstract · 2025-11-04 · 9 matching annotations

96.0%

CRS OC recurrent advanced OC sarilumab ubamatamab

…4.Conclusions A single sarilumab dose before ubamatamab reduced CRS incidence and severity. Pharmacokinetic and pharmacodynamic fin…

640 CHS-114, an anti-CCR8 cytolytic monoclonal antibody demonstrates selective intratumoral Treg depletion and favorable immune remodeling in participants with advanced solid tumors

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

head and neck squamous cell carcinoma advanced solid tumors HNSCC CHS-114

…ansion study is evaluating CHS-114 in advanced solid tumors and head and neck squamous cell carcinoma (HNSCC). CHS-114 has demonstrated an acceptable safety profile …

651 Imneskibart, a human monoclonal antibody (mAb) that binds IL-2 and prevents CD25 binding, + low-dose subcutaneous IL-2: phase 2 update on CPI-refractory melanoma and non-small cell lung cancer (NSCLC)

jitc · abstract · 2025-11-04 · 9 matching annotations

99.3%

Melanoma NSCLC Imneskibart Avelumab

…or regressions and a low incidence of Grade 3/4 adverse events. Melanoma patients with primary resistance to prior doublet immune checkp…

675 Radiopharmaceutical therapy enhances CAR T-cell activity against neuroblastoma by tumor sensitization and tumor microenvironment remodeling

jitc · abstract · 2025-11-04 · 9 matching annotations

94.4%

neuroblastoma solid tumors hematological malignancies SK-N-AS NB [67Cu]Cu-LLP2A [ 67Cu]Cu-LLP2A 67Cu]Cu-LLP2A NIH institutional IACUC RPT

…ell therapy remains less effective against solid tumors such as neuroblastoma (NB) than hematological malignancies. Key obstacles for CAR T c…

679 Combined radiation and adoptive CTL therapy in advanced extramammary paget disease with pulmonary and nodal metastases: a case report and rationale for case series expansion

jitc · abstract · 2025-11-04 · 9 matching annotations

92.6%

melanoma-specific Extramammary Paget’s disease (EMPD)EMPD melanoma solid tumors EBV-related cancers IL-2 Radiother Oncol Adoptive CTL therapy Proc Natl Acad Sci USA+1 more

…:62-68.Chapuis AG, Ragnarsson GB, Nguyen HN, et al. Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire cen…

708 Overcoming resistance to chemo-immunotherapy in non-small cell lung cancer by targeting adenosine metabolism and enhancing CD8+ T cell activation

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

NSCLC non-small cell lung cancer A375 melanoma NSCLC-bearing cisplatin carboplatin cisplatin-induced cisplatin-treated PEG-ADA

… NSCLC cells. For T cell suppression assays, M-MDSCs from human NSCLC were cultured with autologous T cells stimulated with anti-CD3 …

725 Fertility concerns and outcomes among adolescent and young adult males with melanoma receiving immunotherapy

jitc · abstract · 2025-11-04 · 9 matching annotations

97.9%

melanoma microsatellite instability-high (MSI-H) tumors University of Michigan Immune checkpoint inhibitors ICIs first-line immunotherapy

…reatment, toxicity, and fertility characteristics of young male melanoma patients treated with immune checkpoint inhibitors (n=38)…

776 Melanoma tumor cells and immunotherapy cooperatively reprogram bone marrow niches to induce early hematopoietic dysfunction and therapy-related myeloid neoplasms

jitc · abstract · 2025-11-04 · 9 matching annotations

99.6%

Melanoma myelodysplastic syndromes therapy-related myeloid neoplasms immune checkpoint inhibitors immune checkpoint inhibitor therapy Embase PubMed Scopus

…rrow niche alterations and hematopoietic clonal dynamicsResults Melanoma tumor cells infiltrate the bone marrow early, with disseminated…